Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).

Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2013 Apr;47(2):711-25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14.

2.

Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease.

Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, LaFerla FM, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

PLoS One. 2012;7(12):e51432. doi: 10.1371/journal.pone.0051432. Epub 2012 Dec 7.

3.

Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.

Chen Y, Liang Z, Tian Z, Blanchard J, Dai CL, Chalbot S, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2014 Feb;49(1):547-62. doi: 10.1007/s12035-013-8539-y. Epub 2013 Aug 31.

4.

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.

Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S.

J Alzheimers Dis. 2010;19(2):691-704. doi: 10.3233/JAD-2010-1270.

PMID:
20110613
5.

Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.

Park SJ, Kim YH, Nam GH, Choe SH, Lee SR, Kim SU, Kim JS, Sim BW, Song BS, Jeong KJ, Lee Y, Park YI, Lee KM, Huh JW, Chang KT.

Int J Mol Sci. 2015 Jan 22;16(2):2386-402. doi: 10.3390/ijms16022386.

6.

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.

Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, Salkovic-Petrisic M.

J Neural Transm (Vienna). 2015 Apr;122(4):577-92. doi: 10.1007/s00702-015-1394-4. Epub 2015 Mar 26.

PMID:
25808906
7.

Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.

Grieb P.

Mol Neurobiol. 2016 Apr;53(3):1741-1752. doi: 10.1007/s12035-015-9132-3. Epub 2015 Mar 7. Review.

8.

Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose.

Mehla J, Pahuja M, Gupta YK.

J Alzheimers Dis. 2013;33(1):17-21. doi: 10.3233/JAD-2012-120958.

PMID:
22886014
10.

L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.

Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA.

J Neurosci. 2010 Jun 16;30(24):8180-9. doi: 10.1523/JNEUROSCI.0340-10.2010.

11.

Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin.

Yeo HG, Lee Y, Jeon CY, Jeong KJ, Jin YB, Kang P, Kim SU, Kim JS, Huh JW, Kim YH, Sim BW, Song BS, Park YH, Hong Y, Lee SR, Chang KT.

J Alzheimers Dis. 2015;46(4):989-1005. doi: 10.3233/JAD-143222.

PMID:
25881906
12.

Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats.

Murtishaw AS, Heaney CF, Bolton MM, Sabbagh JJ, Langhardt MA, Kinney JW.

Neuropharmacology. 2016 Feb;101:110-22. doi: 10.1016/j.neuropharm.2015.08.044. Epub 2015 Aug 29.

PMID:
26327677
13.

Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.

J Alzheimers Dis. 2011;24(3):421-54. doi: 10.3233/JAD-2011-101635.

PMID:
21297257
14.

Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.

Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H.

Neurol Sci. 2014 May;35(5):741-51. doi: 10.1007/s10072-013-1594-3. Epub 2013 Dec 12.

PMID:
24337945
15.

Mitochondrial Deficits Accompany Cognitive Decline Following Single Bilateral Intracerebroventricular Streptozotocin.

Paidi RK, Nthenge-Ngumbau DN, Singh R, Kankanala T, Mehta H, Mohanakumar KP.

Curr Alzheimer Res. 2015;12(8):785-95.

PMID:
26159195
16.

Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.

Tweedie D, Ferguson RA, Fishman K, Frankola KA, Van Praag H, Holloway HW, Luo W, Li Y, Caracciolo L, Russo I, Barlati S, Ray B, Lahiri DK, Bosetti F, Greig NH, Rosi S.

J Neuroinflammation. 2012 May 29;9:106. doi: 10.1186/1742-2094-9-106.

17.

Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.

Lee Y, Kim YH, Park SJ, Huh JW, Kim SH, Kim SU, Kim JS, Jeong KJ, Lee KM, Hong Y, Lee SR, Chang KT.

J Alzheimers Dis. 2014;38(2):251-67. doi: 10.3233/JAD-130776.

PMID:
23948941
18.

A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.

Song JM, DiBattista AM, Sung YM, Ahn JM, Turner RS, Yang J, Pak DT, Lee HK, Hoe HS.

Exp Neurol. 2014 Feb;252:105-13. doi: 10.1016/j.expneurol.2013.11.023. Epub 2013 Dec 6.

19.
20.

A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.

Luo J, Lee SH, VandeVrede L, Qin Z, Ben Aissa M, Larson J, Teich AF, Arancio O, D'Souza Y, Elharram A, Koster K, Tai LM, LaDu MJ, Bennett BM, Thatcher GR.

Mol Neurodegener. 2016 Apr 29;11:35. doi: 10.1186/s13024-016-0103-6. Erratum in: Mol Neurodegener. 2016;11(1):40.

Supplemental Content

Support Center